Abstract:The immunosuppressive status of the tumor microenvironment (TME) remains poorly defined due to a lack of understanding regarding the function of tumor-associated macrophages (TAMs), which are abundant in the TME. TAMs are crucial drivers of tumor progression, metastasis, and resistance to therapy. Intra- and inter-tumoral spatial heterogeneities are potential keys to understanding the relationships between subpopulations of TAMs and their functions. Antitumor M1-like and pro-tumor M2-like TAMs coexist within tumors, and the opposing effects of these M1/M2 subpopulations on tumors directly impact current strategies to improve antitumor immune responses. Recent studies have found significant differences among monocytes or macrophages from distinct tumors, and other investigations have explored the existence of diverse TAM subsets at the molecular level. In this review, we discuss emerging evidence highlighting the redefinition of TAM subpopulations and functions in the TME and the possibility of separating macrophage subsets with distinct functions into antitumor M1-like and pro-tumor M2-like TAMs during the development of tumors. Such redefinition may relate to the differential cellular origin and monocyte and macrophage plasticity or heterogeneity of TAMs, which all potentially impact macrophage biomarkers and our understanding of how the phenotypes of TAMs are dictated by their ontogeny, activation status, and localization. Therefore, the detailed landscape of TAMs must be deciphered with the integration of new technologies, such as multiplexed immunohistochemistry (mIHC), mass cytometry by time-of-flight (CyTOF), single-cell RNA-seq (scRNA-seq), spatial transcriptomics, and systems biology approaches, for analyses of the TME.

Mechanistic studies of tumor-associated macrophage immunotherapy

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

From Dichotomy to Diversity: Deciphering the Multifaceted Roles of Tumor-Associated Macrophages in Cancer Progression and Therapy.

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Tumor associated macrophages (TAMs): from mechanisms to therapeutic implications

Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights

Tumor-Associated Macrophages in Tumor Immunity

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy

Targeting tumor-associated macrophages for cancer treatment

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Progress in the Research of Tumor Therapy Aimed at Tumor Associated Macrophages

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment

The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy